Actinium Pharmaceuticals, Inc. (ATNM) › Cost of RevenueActinium Pharmaceuticals, Inc. (ATNM) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.Fiscal YearCost of RevenueChange YoY2021$900.0K—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share